SCHEMBL5163931

SCHEMBL5163931

N#Cc1ccccc1NCc1n[nH]c(=O)c2ccccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.57
▸ LMNA P02545 2/20 0.57
▸ MAPT P10636 4/20 0.55
▸ KDM4E B2RXH2 3/20 0.55
▸ GAA P10253 2/20 0.55
▸ HTT P42858 2/20 0.55
▸ MEN1 O00255 1/20 0.55
▸ ALDH1A1 P00352 1/20 0.55
▸ THRB P10828 1/20 0.55
▸ RECQL P46063 1/20 0.55
▸ BLM P54132 1/20 0.55
▸ HPGD P15428 1/20 0.52
▸ TSHR P16473 1/20 0.52
▸ HSD17B10 Q99714 1/20 0.52
▸ HIF1A Q16665 1/20 0.52
▸ AR P10275 7/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.49
▸ PRMT5 O14744 1/20 0.49
▸ PARP1 P09874 1/20 0.47
▸ POLB P06746 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5165966 0.76 MAPT (0.78) KMT2ALMNAMAPTKDM4EGAA
SCHEMBL5162085 0.74 KMT2A (0.64) KMT2ALMNAMAPTKDM4EGAA
SCHEMBL23657600 0.73 LMNA (1.00) KMT2ALMNAMAPTKDM4EGAA
SCHEMBL10679636 0.72 PRMT5 (0.62) LMNAALDH1A1TSHRARSMN1; SMN2
SCHEMBL5160240 0.71 MAPT (1.00) KMT2ALMNAMAPTKDM4EGAA
SCHEMBL5160111 0.71 MAPT (0.75) KMT2ALMNAMAPTKDM4EGAA
SCHEMBL3475619 0.70 KDM4E (1.00) KMT2ALMNAKDM4EGAAHTT
SCHEMBL13858810 0.69 KDM4E (0.66) KMT2ALMNAMAPTKDM4EGAA
SCHEMBL30989583 0.69 ATM (0.56) KMT2ALMNAMAPTKDM4EGAA
SCHEMBL5161752 0.68 MAPT (1.00) KMT2ALMNAMAPTKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1231982-B1 USE OF PHTHALAZINE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES ABBOTT GMBH & CO KG (DE) 2007-03-21 — — EP disclosed
US-6903098-B1 Use of phthalazine derivatives ABBOTT GMBH & CO. (DE) 2005-06-07 — — US disclosed
Send feedback